Recently, a study published by AmericanMarijuana.org found that “the cannabinoid is an effective alternative to opioids,” according to a July article released by ganjapreneur.com. The study included responses from 1,453 CBD consumers who were using it specifically for a pain relief treatment, with the majority of the consumers being both regular users and millenials.
Also, the vast majority of the respondents (97%) reported using fewer opioids to manage their pain symptoms after starting CBD therapy, and an impressive 53% reported only using CBD as their method of pain management.
After reviewing this evidence, Dr. Tory R. Spindle, Ph.D, Postdoctoral Research Fellow at Johns Hopkins University School of Medicine, asserted that, “This study suggests that what we now need is controlled research to understand CBD’s pain-relieving effects (there is surprisingly very little research published in this area on humans). Without controlled studies, it is difficult to know whether some people experience benefits from CBD due to expectancy effects.” In layman’s terms, what Dr. Spindle is saying is that more studies are needed to ascertain whether or not these findings support a “placebo effect” because participants expected their pain symptoms to be lessened by CBD.
It is widely known in the public that anecdotal evidence supports the findings in this study that CBD is an effective method for pain control, but researchers and doctors want to be absolutely sure that this is the whole truth. Federal reglators have issued a warning letter to CBD companies that there is insufficient evidence that cannabinoid is an effective treatment for opioid addiction and pain management.